Objective: Prior studies of prolonged exposure therapy (PE) suggested that reduction of posttraumatic stress disorder (PTSD) precedes reduction in depression, yet no research has collapsed data across multiple studies to examine whether the directionality of reduction remains consistent in larger and diagnostically diverse samples. Thus, the objective of this study is to conduct an evaluation of bidirectional associations between PTSD and depression in PE. Method: Participants (n ϭ 216) from three randomized controlled trials of PE alone, PE ϩ alcohol use disorder treatment, and PE ϩ nicotine use disorder treatment completed weekly PTSD and depression severity measures. First, we analyzed the directional relationship between PTSD and depression over time in 2 single models to separately examine the effects of PTSD on depression and vice versa. Second, we analyzed a combined model to examine the simultaneous effects of reduction in PTSD on reduction in depression over and above the effects of reduction in depression on reduction in PTSD, and vice versa. Results: Two single models suggested that reductions in PTSD lead to reductions in depression and vice versa. The combined models suggested that both directions of change are important and reciprocal. The strength of predictive power from PTSD to depression, and vice versa, is approximately equal. Most significant prediction of PTSD from depression and vice versa occurred early in treatment. Conclusion: The relationship between reductions in PTSD and depression during PE is transactional. Regardless of whether PTSD or depression decreases first, reduction in the other symptom cluster is likely to follow.
reductions in depression that occur over the course of PE are attributable to decreases in PTSD symptoms or whether they are one of the factors leading to PTSD symptom reduction. Alternatively, it is possible that there is a mutually influential relationship between PTSD and depression in treatment.
Clinicians may benefit from the ability to anticipate whether PTSD or depression is likely to initially improve at the outset of PE. For instance, having a clearer understanding of the temporal dynamics in depression and PTSD during treatment could inform the types of in vivo exposures that clinicians assign. For example, if decreases in depression symptoms consistently precede and drive reductions in PTSD symptoms, then clinicians may devote more in vivo exposure exercises to behaviorally activating assignments. In contrast, if the reverse pattern were found, that reductions in PTSD drive reductions in depression, then clinicians may exclusively encourage exposures that promote correcting erroneous perceptions of danger. Additionally, improved understanding of the pattern of change in PTSD and depression may inform the types of cognitions elicited in processing the trauma memory. For instance, clinicians may choose to target depression-related cognitions (e.g., "I am inadequate") or anxiety-related cognitions (e.g., "I cannot handle thinking about the trauma") during processing based on the determined direction of influence between PTSD and depression.
To our knowledge, only three studies to date have examined the relationship between reductions in PTSD and depression symptoms during treatment. In a sample of children and adolescents receiving PE for PTSD, Aderka and colleagues found that reduction in PTSD symptoms more strongly drove reduction in depression symptoms than the converse (Aderka, Foa, Applebaum, Shafran, & Gilboa-Schechtman, 2011) . Whereas prior session depression symptoms accounted for 11% of the variance in PTSD symptom reduction, prior session PTSD symptoms accounted for 64% of the variance in reduction of depression symptoms. These results suggest that among adolescents, reductions in PTSD symptoms may temporally precede and facilitate reductions in depression symptoms over the course of PE.
Another study compared the pattern of influence between PTSD and depression in female adults who were randomly assigned to either PE alone or PE plus cognitive restructuring (PE/CR; Aderka, Gillihan, McLean, & Foa, 2013) . In the context of PE, exposure includes both in vivo exposure, or exposure to avoided people, places and situations, and imaginal exposure, or recounting the trauma memory aloud. PE typically includes the elicitation of trauma-related negative cognitions during the processing portion of the treatment. In Aderka and colleagues (2013) , processing in the PE alone condition was brief (about 10 min), informal, and largely focused on emotional reactions to the imaginal exposure. In contrast, PE/CR included formal and extended (about 25 min) processing, discussion of trauma-related negative cognitions, and cognitive restructuring. In PE alone, reduction in PTSD symptoms fully mediated the effect of PE on depression symptoms and accounted for 80% of change in depression, whereas changes in depression symptoms only partially mediated the effect of PE on PTSD symptoms and accounted for 45% of change in PTSD (Aderka et al., 2013) . In the PE/CR condition, PTSD only partially mediated the effect of treatment on depression (accounting for 60% of change) and depression continued to only partially mediate the effect of treatment on PTSD (accounting for 51% of change; Aderka et al., 2013) . In other words, when exposure was the primary focus of treatment, PTSD symptoms improved first, thereby driving improvements in depression symptoms. In contrast, when exposure was paired with cognitive restructuring and longer, formal processing, the temporal relationship between PTSD and depression symptoms was more reciprocal, though PTSD changes accounted for 9% greater variance in depression than the converse. As a major component of the standard PE treatment package includes formal processing (Cooper, Zoellner, Roy-Byrne, Mavissakalian, & Feeny, 2017; Foa, Hembree, & Rothbaum, 2007; Foa, Huppert, & Cahill, 2006; Foa & Rauch, 2004) , these findings suggest that a reciprocal pattern of change should be expected from PE across multiple trials, though PTSD may continue to influence depression to a marginally greater extent.
The temporal course of PTSD and depression change has been explored in one study of cognitive processing therapy (CPT), a cognitively based PTSD treatment (Liverant, Suvak, Pineles, & Resick, 2012) . As with the dismantling goal of Aderka and colleagues (2013) , the goal of the trial was to isolate CPTs active ingredients, namely (a) written accounts of the trauma and its impact and (b) cognitive processing, facilitated through Socratic questioning of distorted cognitions and worksheets to develop more balanced thinking, in a sample of women with PTSD. Unlike PE, CPT does not include in vivo exposure. Thus, the study compared CPT alone, which included both written accounts of the trauma and challenging distorted cognitions, to cognitive processing of the trauma only (CPT-C), and written accounts of the trauma only (WA). Across all three conditions, change in PTSD and depression occurred concurrently. However, there was no evidence for temporal precedence of symptom change. In other words, PTSD and depression both changed over the same time-period, but PTSD did not influence depression change and depression did not influence PTSD change.
One possible explanation for the differences between Liverant and colleagues (2012) and Aderka and colleagues (2013) is that CPT does not include in vivo exposure, an active PE ingredient. Thus, perhaps the physically active nature of in vivo exposure, in which participants are confronting real-world challenging situations, coupled with imaginal exposure of the trauma memory and cognitive processing of trauma-related cognitions alters the association between PTSD and depression to one of a more reciprocal nature. It is conceivable that approaching anxiety-provoking circumstances may serve the same function as behavioral activation in the treatment of depression (Cuijpers, van Straten, & Warmerdam, 2007; Sturmey, 2009) . Thus, in vivo exposures developed with a goal of reducing PTSD symptoms may also reduce depression. Alternatively, these exposures may reduce symptoms of depression first, thereby encouraging greater engagement with future exposure exercises that later reduce PTSD symptoms. Further, there may be an interactional effect of combining in vivo exposure, imaginal exposure, and cognitive processing. This interaction may alter the association between PTSD and depression such that it diverges from the effects of combining written trauma accounts and cognitive restructuring (typical of CPT).
Thus, evidence for the direction of reductions in PTSD and depression is mixed. Some studies found that reduction in PTSD symptoms drove reductions in depression symptoms (Aderka et al., 2011 in adolescents; Aderka et al., 2013 for PE alone in adults). This document is copyrighted by the American Psychological Association or one of its allied publishers.
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Others found a reciprocal pattern of change between PTSD and depression, though PTSD continued to exert a marginally greater influence on depression than the reverse (Aderka et al., 2013 for PE/CR). Still others found concurrent decreases in PTSD and depression without mutual influence between them (Liverant et al., 2012, for CPT) . However, some limitations of the prior studies may account for these discrepant findings. In all three studies, the effect of PTSD on depression was examined in separate models from the models that examined the effect of depression on PTSD. While separate models allow for an understanding of the independent relationship between these variables, a model that combines the cross-lagged influence of both PTSD on depression and depression on PTSD is required to accurately test the temporal precedence of symptom reduction. A combined model provides a more conservative approach, because each predictive path is estimated above and beyond the influence of every other model path. Thus, the criterion for achieving significant temporal prediction is more stringent. Second, each of the three studies discussed above included data from only single samples, including children and adolescents or female adults (Aderka et al., 2013; Liverant et al., 2012 The purpose of the current study was to investigate the relationship between PTSD and depression symptoms over the course of three PE studies previously reported elsewhere (Foa et al., 2017; Foa, McLean, Capaldi, & Rosenfield, 2013; Zalta et al., 2014) , each of which included formal cognitive processing alongside imaginal exposure. The combination of the three samples allowed for enhanced power to detect relationships across PTSD and depression that would not be possible without a large sample size. We hypothesized that in single models, consistent with two of the three studies discussed above (Aderka et al., , 2013 for PE alone), reduction in PTSD symptoms would have a stronger effect on reduction in depression symptoms. In addition, the current study sought to extend the prior research by examining change over time in PTSD and depression in a combined model. To our knowledge, no prior research has used this approach, and the novel nature of this exploration warranted tentative hypotheses. Nevertheless, we hypothesized that when PTSD and depression were analyzed in a combined model, a reciprocal pattern of change would emerge. This hypothesis was based on several considerations. First, one single-model study demonstrated reciprocity of change between PTSD and depression (Aderka et al., 2013 , for PE/CR), providing a precedent for mutual influence between PTSD and depression and indicating that prior findings of the temporal precedence of PTSD on depression may be unlikely to survive a more conservative approach. Second, another singlemodel study demonstrated concurrent (though not mutually influential) changes in PTSD and depression (Liverant et al., 2012) , and several other PE trials have demonstrated that PE reduces both PTSD and depression without formally testing their relative influence on one another (Eftekhari et al., 2013; Foa et al., 1999 Foa et al., , 2005 Foa et al., , 2017 Keller et al., 2014; Resick et al., 2012) . As PTSD and depression tend to be moderately correlated (Kessler et al., 2005) , it follows that each variable influences the other. Thus, we hypothesized that the conservative, combined model would result in reciprocal reduction in PTSD and depression, wherein PTSD reduction would predict depression reduction and vice versa.
Method
All studies were approved by the Institutional Review Board (IRB) and all participants completed informed consent at the study outset.
Study 1: Treatment of PTSD and smoking (Foa et al., 2017) Participants. Participants (n ϭ 142) were adults who met Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition (DSM-IV; American Psychiatric Association, 2000) criteria for PTSD, had been smoking 10ϩ cigarettes/day for the past year, and were treatment-seeking. The average age in the sample was 42.7 years (SD ϭ 9.9), and participants were mostly male (60.6%) and Black (75.3%; see Table 1 for more detail).
Measures.
Posttraumatic Diagnostic Scale (PDS).
The PDS is a 17-item self-report scale that measures frequency of DSM-IV PTSD symptoms of hyperarousal, avoidance, and re-experiencing over the course of the past week (Foa, Cashman, Jaycox, & Perry, 1997 ) on a 0 (not at all or only 1 time) to 3 (5 or more times per week/almost always) point Likert scale. The PDS was completed weekly and internal consistency was high (␣ ϭ .95; see Table 2 for means and SD).
Beck Depression Inventory (BDI). The BDI is a 21-item self-report measure of depression that is rated on a 0-to 3-point Likert scale (Beck, Ward, Mendelson, Mock, & Erbaugh, 1961) . The BDI was also completed weekly and had high internal consistency (␣ ϭ .97).
Procedure. Participants were randomized to Varenicline (Chantix) and smoking cessation counseling (VARCC) or VARCC plus 12 weekly sessions of PE (PE ϩ VARCC). Only participants who received PE were included in the current study (n ϭ 72). Eight patients (12%) randomized to PE ϩ VARCC dropped out before treatment completion.
Treatments.
Varenicline. One week before target quit dates, participants were provided with Varenicline, an FDA-approved selective ␣4␤2 neuronal nicotinic acetylcholine receptor (nAChR) partial agonist used to aid smoking cessation, which was titrated as described elsewhere (see Foa et al., 2017) .
Smoking cessation counseling. Smoking cessation counseling included medication management (as seen in Project COM-BINE; Anton et al., 2006) and 20-to 30-min weekly counseling sessions focusing on general support, progress and adherence monitoring, motivational interviewing, and problem solving.
Prolonged exposure. After each smoking cessation session, participants received 90-min PE sessions conducted by doctorallevel therapists trained in PE. Key treatment components in PE This document is copyrighted by the American Psychological Association or one of its allied publishers.
include in vivo exposure (confronting trauma-reminders in daily life), imaginal exposure (repeated revisiting of traumatic memories) followed by processing (discussing negative cognitions, feelings arising from the recounting of the trauma memory, and general trauma-related negative cognitions).
Study 2: Biological Treatment of PTSD (Zalta et al., 2014)
Participants. Participants (n ϭ 64) were treatment-seeking female sexual and nonsexual assault survivors with a DSM-IV principal PTSD diagnosis. Participants were on average 39.1 years old (SD ϭ 12.6) and were mostly Black (56.3%) or White (39.1%; see Table 1 for more detail). Participants' treatment was part of a study that included assessment of hypothalamic-pituitary-adrenal (HPA) axis functioning to determine the psychological and biological mechanisms of PE. Specifically, in addition to completing PE sessions, participants provided samples of urinary cortisol, norepinephrine, salivary cortisol, and physical activity in the privacy of their home.
Measures. As in Study 1, participants completed weekly PDS (␣ ϭ .94) and BDI (␣ ϭ .96) measures.
Procedure. Participants were enrolled in a PE treatment study that included the assessment of the hypothalamic pituitary adrenal (HPA) axis functioning. Participants were randomly assigned to either 10 weeks of weekly 90-min PE sessions (n ϭ 53) or weekly phone contact followed by the option to receive PE (n ϭ 11; for more detail on procedures, see Zalta et al., 2014) . All participants This document is copyrighted by the American Psychological Association or one of its allied publishers. This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
who received PE either immediately or after the waitlist were included in the current study. As with Study 1, PE in the current study included psychoeducation about PTSD, breathing retraining, in vivo exposure, and imaginal exposure followed by processing.
Study 3: Treatment of PTSD and Alcohol Dependence (Foa, Yusko, et al., 2013)
Participants. Participants (n ϭ 165) met DSM-IV criteria for current alcohol dependence (AD) and PTSD, were on average 42.8 years old (SD ϭ 9.8), and were mostly male (65.5%) and Black (63.6%; see Table 1 for more details).
Measures. Participants completed the PDS (␣ ϭ .95) and the BDI-II (␣ ϭ .96; Beck, Steer, & Brown, 1996) each week. Like the BDI, the BDI-II is a 21-item self-report measure of depression rated on a 0-to 3-point Likert Scale. Given the high degree of similarity in range of scores, item content, and severity cut-offs on the BDI and BDI-II, as well as the high correlation between them (r ϭ .84 -.92; Wang & Gorenstein, 2013) , these measures were collapsed across studies. An alternative would be to calculate standard scores, but this approach is not recommended for multilevel or structural equation longitudinal models because of the loss of mean-level changes over time (Moeller, 2015) .
Procedure. All participants first completed outpatient detoxification (defined as three or more consecutive days of alcohol abstinence as measured by self-report and breathalyzer testing) and were randomly assigned to one of four treatment conditions: PE ϩ Naltrexone (n ϭ 40), PE ϩ Placebo (n ϭ 40), Naltrexone ϩ no PE (n ϭ 42), Placebo ϩ no PE (n ϭ 43). Patients in all conditions received concurrent supportive counseling focusing on alcohol use and medication management. Only patients who received PE were included in the current study (n ϭ 80). Fourteen participants (35%) and 15 participants (38%) dropped out of the study before treatment completion for PE ϩ Naltrexone and PE ϩ Placebo, respectively. For full study procedures, see Foa, Yusko, et al. (2013) .
Treatments. Prolonged exposure (PE). PE was identical in format and length of sessions to Studies 1 and 2; however, participants in this study were provided with 12, 90-min weekly sessions of PE, plus, if indicated, 6 additional bi-weekly PE sessions or general discussion about relevant life issues. PTSD and depression ratings from the first 10 sessions only were included in the current study.
Naltrexone. Naltrexone is an opiate antagonist treatment for alcohol dependence approved by the U.S. Food and Drug Administration. In the present study, participants were started on a 50 mg/d dose for a minimum of 3 days, followed by a titration within 1 week up to the target dose of 100 mg/d. Compliance with the regimen for dosing was assessed via weekly pill counts in the first 3 months and bi-weekly counts for the next 3 months.
Supportive counseling. All participants received 18, 30 -40 min sessions of supportive counseling using the BRENDA model (Starosta, Leeman, & Volpicelli, 2006) . Specifically, these sessions entailed the dispensation of medication, compliance monitoring, provision of education about alcohol use disorder symptoms, and offering of support/advice around drinking, in line with techniques aimed at enhancing compliance through motivational interviewing (Miller & Rollnick, 1991) . BRENDA sessions were provided on the same schedule as PE sessions (i.e., weekly for the first 3 months, and then bi-weekly in the later 3 months).
Data Analysis
All analyses used an intent-to-treat sample. Following examples from prior literature (Aderka et al., 2013; Zalta et al., 2014) , we first ran single direction mixed-effects multilevel models with random intercepts and robust SEs in Stata Version 14 (StataCorp, 2015) . Study 2 had only 10 PE sessions, and, therefore, only the first 10 sessions of PE were examined across all three studies. The first model determined the cross-lagged effects of depression on PTSD symptoms, controlling for PTSD symptoms at the prior session (termed the autoregressive effect). The second model determined the cross-lagged effects of PTSD on depression symptoms, controlling for depression symptoms at the prior session. These models were used to calculate the effect sizes of the cross-lagged effects. To account for inclusion of participants across three studies with four variants on PE treatment (PE ϩ VARCC from Study 1, PE alone from Study 2, PE ϩ Placebo and PE ϩ Naltrexone from Study 3), the models were tested with and without study as a covariate. Intraclass correlation coefficients (ICC) supported the use of clustering by participants (ICC for PDS ϭ .54; ICC for BDI ϭ .68). This document is copyrighted by the American Psychological Association or one of its allied publishers. This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
Next, cross-lagged panel analyses were conducted following procedures outlined in Martens and Haase (2006) and Brown et al. (2015) using MPlus Version 7 (Muthén & Muthén, 2012) to compare the relationship between PTSD and depression reductions in a combined model. This procedure involves four iterations of model testing to determine the directionality between PTSD and depression symptoms described visually in Figure 1 . Model 1, referred to as the autoregressive model, accounted for only change over time (that ultimately was in the direction of a reduction and is hereafter referred to as such) within depression and PTSD (see Figure 1 Paths A). Specifically, PTSD symptoms at Session 1 were entered as a predictor of PTSD symptoms at Session 2, and PTSD symptoms at Session 2 were entered as a predictor of PTSD symptoms at Session 3, and so on. The autoregressive model included the same paths in depression, with depression at Session 1 entered as a predictor of depression at Session 2, and so on. In addition, we correlated the baseline PDS and BDI scores, as well as the errors of each subsequent observation across PDS and BDI (i.e., error of PDS at Session 2 was correlated with error of BDI at Session 2). More important, model fit was improved by adding predictive paths from the Session 1 observation of each variable to each subsequent observation of the variable; this approach is justified because baseline scores on a variable are likely to influence subsequent scores on that variable. In addition, model fit was improved by adding correlated errors or paths within a measure as recommended by modification indices; no cross-measure parameters were included based on recommendations from modification indices alone to avoid altering associations between measures.
1 These modification indices were decided upon before directional model paths were added between PTSD and depression so as not to influence the pattern of results between these variables.
Model 2 included the paths specified from Model 1 as well as paths from PTSD at a given session to depression at the subsequent session (i.e., PTSD at Session 1 to depression at Session 2; see Figure 1 Paths B). Model 3 included the paths specified from Model 1 as well as paths from depression at a given session to PTSD at the subsequent session (i.e., depression at Session 1 to PTSD at Session 2; see Figure 1 Paths C). Model 4 included all paths specified in Models 1-3. In other words, this model included autoregressive paths (A) as well as directional paths (B and C) between PTSD and depression at all observations.
Comparison between Models 1 and 2 allowed for a determination of improvement in model fit after accounting for prediction of depression from PTSD symptoms (paths B in Figure 1) . In other words, this comparison allows for a determination of whether adding paths predicting depression from PTSD improves model fit compared with the basic autoregressive model. Comparison between Models 1 and 3 allowed for a determination of improvement in model fit after adding paths predicting PTSD from depression (paths C in Figure 1 ). That is, this comparison allowed for a determination of whether adding paths predicting PTSD from depression improved model fit compared with the basic autoregressive model. Comparisons between Models 2 and 4 allowed for a determination of the importance of paths that are left out of Model 2 (specifically, paths wherein depression predicts PTSD, paths C) to determine the relative importance of these paths compared with the full model (including paths A, B, and C). Comparison between Models 3 and 4 allowed for a determination of the importance of paths that are left out of Model 3 (specifically, paths wherein PTSD predicts depression, paths B) to determine the relative importance of these paths compared with the full model (including paths A, B, and C). Models were calculated using maximum likelihood estimation with robust SEs using the MLR option in MPlus and were clustered by participant. These sandwich estimators are more accurate than maximum likelihood in the face of normality violations in SEs and 2 estimation (Maas & Hox, 2004) , without significantly changing parameter estimates (Hox, Maas, & Brinkhuis, 2010) .
Finally, two last models were run to test whether model fit was worsened by constraining the cross-lagged paths to be equaled versus freely estimated. A correlation matrix was estimated using full information maximum likelihood to account for missing data, using the corFiml function of the "psych" package in R (Revelle, 2013 ) that was imported into MPlus for model testing.
Models were statistically compared using the Satorra-Bentler scaled 2 (Satorra & Bentler, 2001 ), wherein 2 is divided by a correction value to account for improved approximation in instances of nonnormality, such as in clinical measures that are positively skewed toward the end of treatment. This comparison takes into consideration degrees of freedom, 2 , and a scaling factor for each 2 value. In addition to Satorra and Bentler's scaled 2 , model fit was determined using the comparative fit index (CFI; recommended value greater than .95; Hu & Bentler, 1995) , standardized root mean squared residual (SRMR; recommended value less than .08; Hu & Bentler, 1999) , and change in Akaike Information Criterion (AIC) from the base model to the final model (Akaike, 1976) . Root mean squared error of approximation (RMSEA; compared with a recommended value less than .06; Hu & Bentler, 1999; Steiger & Lind, 1980) was also reported, but the low degrees of freedom in the models reduce confidence in this fit index because the values tend to be arbitrarily inflated. Therefore, these values should be interpreted with caution, particularly when the sample size is relatively small (Kenny, Kaniskan, & McCoach, 2015) . It is important to note that path models can be appropriately estimated with even small degrees of freedom because of the reliance on observed variables rather than latent variables used in other types of structural equation modeling (Kenny et al., 2015) .
Of the original 216 participants from the three studies, five participants were missing all observations on the PDS and BDI and were, therefore, excluded from data analyses. In addition, some participants did not have enough data for inclusion in the single direction analyses, which required at least two scores on the outcome variable and at least one on the predictor variable to be calculated. The single direction analyses included 204 participants for the PDS outcome and 203 for the BDI outcome. The combined model maximized available data across both measure, and thus this model included 211 participants.
1 Model fit was further improved by adding the following correlated errors: BDI at Sessions 4 and 7 and Sessions 8 and 9, and correlated errors between PDS at Sessions 6 and 7 and Sessions 7 and 8. Additionally a path was included from BDI at Session 5 to Session 7. These paths were added when building the autoregressive model to ensure appropriate model fit before adding directional parameters across measures. The pattern of results was not changed when these parameters were removed, but model fit was worsened with their exclusion. These are not documented in Figure  2 for easier visualization. This document is copyrighted by the American Psychological Association or one of its allied publishers.
Results

Correlation Between PTSD and Depression
Baseline PTSD and depression were moderately correlated across all three studies (r ϭ .56). 
Single Direction: Cross-Lagged Paths Predicting Depression From PTSD
Bidirectional Model Testing
When all participants were included, both Models 2 and 3 had significantly better fit than Model 1, suggesting that models including paths from PTSD to depression (see Figure 1 paths B) and from depression to PTSD (see Figure 1 paths C) outperformed models that included only change over time within depression or PTSD (see Figure 1 paths A; see Table 3 ). Models 2 (excluding paths from depression to PTSD; the model included paths A and B) and 3 (excluding paths from PTSD to depression; the model included paths A and C) had significantly worse model fit compared to Model 4 (the model included paths A, B, and C), suggesting that Model 4 was the best-fitting model according to Satorra-Bentler scaled 2 comparisons. In addition, other indices of model fit (including CFI and SRMR) indicated that this model performed well (see Table 4 ).
2
When cross-lagged parameters (paths B and C) were constrained to be equal, model fit was not significantly worsened compared to when the parameters were freely estimated (see Table  3 , column 6).
An examination of individual parameters of the directional paths in the model (see Figure 2 , Part A) revealed that the predictive power of depression on PTSD (paths C) was strongest early in treatment, particularly from Sessions 1 to 2 and then again from Sessions 4 to 5, and that these paths were no longer significant toward the latter half of treatment. In contrast, the predictive power of PTSD on depression ("paths B") was particularly strong from Session 3 (when imaginal exposure is first introduced; see Figure  2 , Part B) to Session 4. When bidirectional paths (B and C) were included, this general pattern was maintained.
Discussion
To our knowledge, this is the first investigation of the relationship between reductions in PTSD and depression across multiple trials of PE in a combined sample of racially diverse adult men and women. The results of the study were largely consistent with our hypotheses. First, consistent with Aderka and colleagues (2011), our initial analyses revealed that in single outcome models, crosslagged changes in PTSD were associated with changes in depression and vice versa. The effect size was larger for the model predicting depression from PTSD (d ϭ .50 vs. d ϭ .41). However, this difference was smaller compared with that reported in colleagues (2011, 2013 for PE alone with informal and brief processing) and was more consistent with findings reported in 2 Sensitivity analyses were also run wherein only participants with a baseline diagnosis of major depressive disorder were included. These results were identical to the results with the full sample. Specifically, the bidirectional model had superior model fit ( 2 ϭ 228.677, dfϭ 123, scaling correction factor: 1.088) compared with the autoregressive model (i.e., Model 1: 2 ϭ 272.744, df ϭ 141, scaling correction factor: 1.1023), the model in which PTSD predicted depression (i.e., Model 2: 2 ϭ 245.71, df ϭ 132, scaling correction factor: 1.0947), and the model in which depression predicted PTSD (i.e., Model 3: 2 ϭ 247.66, df ϭ 132, scaling correction factor: 1.0989). This document is copyrighted by the American Psychological Association or one of its allied publishers. This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
Aderka and colleagues (2013) for PE/CR (with formal and extended processing) in which PTSD only accounted for about 9% more variance in depression than the opposite.
As noted earlier, in the present study we extended upon the findings from prior research by calculating models that simultaneously estimated the predictive power of depression and PTSD throughout the course of PE. Results from the conservative combined model suggested that changes in PTSD and depression were reciprocal in PE. That is, as PTSD symptoms improved in PE treatment, depression symptoms improved, and vice versa. This is an encouraging finding in terms of understanding the mechanisms of change of PE, because regardless of whether depression or PTSD symptoms improve first, change in the other symptom is likely to follow. The results are consistent with the findings from the single model exploration of Aderka and colleagues (2013) for PE/CR in which PTSD and depression were mutually influential. All three of the current PE studies included formal cognitive processing after imaginal exposure, which differs from cognitive restructuring but has overlapping elements. Thus, it is not surprising that the pattern of results more closely mirrored the PE/CR outcomes than the PE alone outcomes from Aderka and colleagues (2013) . As with Liverant and colleagues' (2012) study in CPT, there were concurrent reductions in PTSD and depression, but unlike Liverant and colleagues' study, the changes between PTSD and depression were mutually influential.
There are several possible reasons for differences in current study findings compared with prior research. First, the current study used a more conservative combined model whereas Liverant and colleagues (2012) used a single model. However, single model results from the current study demonstrate temporal associations between PTSD and depression that were not observed in Liverant and colleagues' (2012) study. Second, Liverant and colleagues (2012) included only female participants whose index trauma was either a sexual or physical assault, whereas the current study included both men and women with mixed index traumas. Perhaps either gender or trauma type influenced the association between PTSD and depression over time. For instance, gender may inadvertently influence the type of in vivo exposures selected for practice, and index trauma type very likely influences the type of in vivo exposures. However, to our knowledge there are no studies that address this possibility. Alternatively, gender and type of index trauma may influence trauma-related cognitions, resulting in altered associations between PTSD and depression. Negative traumarelated cognitions about the self are associated most strongly with PTSD in men and depression in women (Daie-Gabai, Aderka, AllonSchindel, Foa, & Gilboa-Schechtman, 2011) . Women have more severe PTSD symptoms than men, perhaps due in part to a greater likelihood of exposure to sexual abuse (Moser, Hajcak, Simons, & Foa, 2007) , which may also alter the association between PTSD and depression in a mixed-gender sample. Similarly, those who have experienced interpersonal traumas tend to hold more dysfunctional beliefs, particularly in regard to self-blame, than those who have experienced noninterpersonal traumas (Su & Chen, 2008) . The current study did not have sufficient power to address these possible moderators. Finally, the differences in findings between the current study and Liverant and colleagues (2012) may be because of the active treatment components in CPT compared with PE. Whereas CPT includes written exposure and cognitive restructuring, PE includes imaginal exposure, processing, and in vivo exposure. As discussed earlier, perhaps in vivo exposure promotes a mutually influential association between PTSD and depression in PE.
Findings from the current study also differ from the findings of Aderka and colleagues (2011) , in which PTSD was a more powerful predictor of depression than was depression a predictor of PTSD. Several explanations may account for the inconsistency with our findings. First, all participants in the current study were adults, whereas Aderka and colleagues' (2011) sample included only adolescent participants. Prior research has provided some evidence for altered temporal precedence between the development of PTSD and depression in adults and children. Specifically, rates of depression after childhood sexual abuse are lower in children and are higher in adults with a history of childhood sexual Note. AIC ϭ Akaike Information Criterion; BIC ϭ Bayesian Information Criterion; RMSEA ϭ root mean squared error of approximation; CFI ϭ comparative fit index; SRMR ϭ standardized root mean squared residual. This document is copyrighted by the American Psychological Association or one of its allied publishers.
abuse, perhaps reflecting delayed effects of stress (Andersen & Teicher, 2008) . However, this altered progression of symptom onset over development may not translate into altered patterns of symptom improvement during treatment. This should be explored in future studies. Second, the current study had a larger sample size that consisted of racially diverse participants from three studies of PE, thereby improving power. Third, the current study included participants with co-occurring alcohol use disorder or heavy tobacco smoking, which increases generalizability of the findings, but also provides a more diagnostically complex sample. It is possible that diagnostic comorbidity may result in more complex associations between symptoms over time, though we are not aware of any research on this topic. Fourth, the models in the current study controlled for the impact of PTSD on depression while simultaneously examining the impact of depression on PTSD, and vice versa. As such, this simultaneous model is more conservative in estimating the relationship between PTSD and depression compared with models that do not allow for bidirectionality. Our findings suggest that future studies may benefit from utilizing simultaneous models, as opposed to separate single direction models, to better parse the reciprocal relationship between PTSD and depression and how this bidirectional relationship changes over the course of treatment. Fifth, the bidirectional association among PTSD and depression may be because of some ‫ءء‬ p Ͻ .01, ‫ء‬ p Ͻ .05. PDS ϭ Posttraumatic Diagnostic Scale; BDI ϭ Beck Depression Inventory; S1-S10 ϭ Session 1 through Session 12. Baseline observations (i.e., PDS-S1 and BDI-S1) were correlated, as were error terms at each subsequent observation (i.e., error terms for PDS-S3 and BDI-S3 were correlated, as were PDS-S6 and BDI-S6, etc.), but for clearer visualization, these were not included in the diagrams. Parameters were added based on modification indices including: BDI at Session 5 predicting BDI at Session 7, correlated errors between BDI at Sessions 4 and 7 and Sessions 8 and 9, and correlated errors between PDS at Sessions 6 and 7, 7 and 8. These are not documented in Figure 2 for easier visualization and the pattern of results was not altered with the exclusion of these modification indices, in that the bidirectional model continued to provide superior model fit. This document is copyrighted by the American Psychological Association or one of its allied publishers.
degree of overlap in diagnostic symptoms between these disorders. Correlations between the PDS and BDI were moderate in this study (r ϭ .56) and, therefore, were not large enough to suggest that these measures capture the same construct. Similarly, prior research has supported the distinct nature of the disorders, as a factor analysis across all symptoms of both diagnoses revealed that they are best characterized by two factors rather than one (Blanchard, Buckley, Hickling, & Taylor, 1998) . Finally, 71% of the total sample had current major depression, compared to 12, 41, and 52% of colleagues (2011, 2013) , and Liverant and colleagues (2012) , respectively. The larger proportion of individuals with depression in the current study may partially account for differences in the directional relationship between PTSD and depression. For instance, a sample with fewer patients with depression would result in a floor effect on change in depression symptoms. However, this would likely affect both the influence of depression on PTSD and the converse and, therefore, this is unlikely to be the only explanation for differences between the current and prior studies. Several limitations should be considered. First, the number of PE sessions differed across the studies. Because Study 2 had 10 PE sessions, only the first 10 sessions of PE were examined across all three studies. It is possible that the direction of the relationship between reduction in PTSD and depression symptoms may change after 10 sessions. Future studies should investigate this possibility, though in the present study, symptom change occurred primarily before Session 10, thus improving confidence in these results. Second, because model estimation for the combined approach is computationally demanding, investigation of potential moderators was not conducted in this study. It is possible that other factors, including comorbid major depressive disorder, may influence the direction of change between PTSD and depression symptoms. While the samples included in this study had comorbid conditions that allow for greater generalization to the larger population, including alcohol and nicotine use disorders, none of the studies in the current sample were focused on recruiting participants with comorbid depression. Nevertheless, the range of depression at the first session was moderate (i.e., BDI scores ranged from 0 to 50, with an average score of 19.5, SD ϭ 10.9) and the majority of participants were at least mildly depressed, thereby further increasing generalizability. Furthermore, a sensitivity analysis which restricted the sample to include only those with a diagnosis of major depressive disorder did not alter the pattern of results. Third, because we were interested in reduction in PTSD and depression over the course of PE, we did not include non-PE groups in the analyses. Future research should examine the overall change in PTSD and depression over time in naturalistic samples or in comparison treatments.
Additionally, two of the three studies included a concurrent treatment either for nicotine or alcohol use disorders, which is an important limitation of the study. For this reason, it is impossible to determine the impact of PE alone on the change in PTSD and depression over time, and future investigations should explore the relationship between PTSD and depression within a stand-alone PTSD intervention. In the nicotine dependence study (Study 1), participants received both Varenicline and 20 -30 min of weekly supportive counseling alongside PE. Supportive counseling occurred before PE sessions, such that PE sessions were identical to those conducted in other PE trials, including the studies used in the present study. Furthermore, PE plus Varenicline and supportive counseling conditions outperformed supportive counseling and Varenicline alone on both PTSD and depression outcomes (Foa et al., 2017) . However, there was not a placebo condition, making it difficult to disentangle the relative influence of Varenicline versus PE on PTSD and depression symptoms. In the PTSD and alcohol use disorder study (Study 3), participants were randomized to receive PE either in combination with naltrexone or pill placebo (among other comparisons not included in the current study; Foa, Yusko, et al., 2013) . There were no differences in PTSD outcomes between the group that received PE with naltrexone or the group that received PE with placebo. This suggests that naltrexone was unlikely to influence PTSD in this trial. However, this trial did not report on depression outcomes. Thus, as stated above, the pattern of change between depression and PTSD cannot be attributed solely to PE as it may have been influenced by the concurrent treatments. Just as future research should explore the direction of change in PTSD and depression in stand-alone PE, examining this pattern of change in PE relative to other PTSD treatments, including CPT and present centered therapy, is warranted. These comparisons will improve our conceptual understanding of whether the mutual influence of PTSD and depression is indeed specific to PE or is characteristic of emotional responding to PTSD treatments more broadly.
In summary, to our knowledge, this is the first study to demonstrate a reciprocal pattern of symptom reduction between PTSD and depression over the course of PE in a large sample comprised of three different studies. Consistent with prior research on change in PTSD and depression during evidence-based treatments for PTSD, these results suggest that PTSD symptoms influence subsequent reductions in depression symptoms and vice versa. These results imply that whether patients initially experience relief from depression or PTSD during PE, overall reductions in both symptom constructs are likely to occur.
